Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Rather than focusing solely on a final weight target, celebrating intermediate achievements supports mental health throughout the journey
By pairing low-dose GLP-1 medications with rigorous blood diagnostics and behavioral coaching, Noom aims to intercept metabolic dysfunction before it becomes chronic disease
Choose transparency
A recent phase 2 trial investigated the triple biased GLP-1/GIP/GCC receptors agonist retatrutide (LY3437943) in 338 patients with a mean age of 48 years and BMI of 37.3 kg/m 2 without diabetes (prediabetes in 36% participants) showing BW and WC reduction ranging from 8.7% to 24.2% and 6.5 cm to 19.6 cm in the 1 mg and 12 mg dose groups, respectively, at 48 weeks 41
Schedule follow-ups : Regular check-ins with your provider ensure your plan is working for you safely
You need to talk to your doctor if youre pregnant or nursing, too - even though Dr
US$ 29.55
US$ 22.59
US$ 27.12
US$ 28.35
US$ 20.93
US$ 22.84
US$ 27.54
